{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:25:51Z","timestamp":1790040351540,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009311","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000}}],"reference-count":84,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009311.pub2","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T17:56:29Z","timestamp":1432749389000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation"],"prefix":"10.1002","volume":"2015","author":[{"given":"Daniel KL","family":"Cheuk","sequence":"first","affiliation":[{"name":"The University of Hong Kong, Queen Mary Hospital; Department of Pediatrics and Adolescent Medicine; Pokfulam Road Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan KS","family":"Chiang","sequence":"additional","affiliation":[{"name":"The University of Hong Kong, Queen Mary Hospital; Department of Pediatrics and Adolescent Medicine; Pokfulam Road Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shau Yin","family":"Ha","sequence":"additional","affiliation":[{"name":"The University of Hong Kong, Queen Mary Hospital; Department of Pediatrics and Adolescent Medicine; Pokfulam Road Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey CF","family":"Chan","sequence":"additional","affiliation":[{"name":"The University of Hong Kong, Queen Mary Hospital; Department of Pediatrics and Adolescent Medicine; Pokfulam Road Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD009311.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomised trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD009311.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bmt.1701321","article-title":"Parenteral glutamine protects hepatic function during bone marrow transplantation","volume":"22","author":"Brown","year":"1998","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD009311.pub2-BIB0003|cit3","first-page":"380","article-title":"Defibrotide (DF) for the prevention of hepatic veno-occlusive disease (VOD) in paediatric stem cell trans-plantation: Results of a prospective randomised Phase II\/III, multicenter trial","volume":"169","author":"Corbacioglu","year":"2010","journal-title":"European Journal of Pediatrics"},{"issue":"22","key":"10.1002\/14651858.CD009311.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1182\/blood.V114.22.653.653","article-title":"Defibrotide (DF) for the prevention of hepatic veno-occlusive disease (VOD) in paediatric stem cell transplantation: Results of a prospective phase II\/III randomised, multicenter study","volume":"114","author":"Corbacioglu","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0005|cit5","first-page":"S1","article-title":"Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: Final results of a prospective phase II\/III multicenter study","volume":"45","author":"Corbacioglu","year":"2010","journal-title":"Bone Marrow Transplantation"},{"issue":"9823","key":"10.1002\/14651858.CD009311.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD009311.pub2-BIB0007|cit7","first-page":"620a","article-title":"Prevention of veno-occlusive disease (VOD) of the liver after marrow and blood progenitor cell transplantation: a prospective randomised study of different prophylactic regimens","volume":"86","author":"Demuynck","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0008|cit8","first-page":"250a","article-title":"A randomised double-blind trial of prophylactic ursodeoxycholic acid (UDCA) vs placebo to prevent veno-occlusive disease of the liver (VOD) in patients undergoing allogeneic bone marrow transplantation (BMT)","volume":"84","author":"Essell","year":"1994","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomised, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Annals of Internal Medicine"},{"issue":"11 Part 1","key":"10.1002\/14651858.CD009311.pub2-BIB0010|cit10","first-page":"503","article-title":"A randomized trial of heparin plus anti-thrombin III (ATIII) vs. heparin alone to prevent VOD after HSCT","volume":"106","author":"Jung","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD009311.pub2-BIB0011|cit11","first-page":"414a","article-title":"Low molecular weight heparin in prophylaxis of veno-occlusive disease in patients undergoing bone marrow transplantation","volume":"88","author":"Lee","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD009311.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","article-title":"Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation","volume":"47","author":"Marsa-Vila","year":"1991","journal-title":"European Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD009311.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1705724","article-title":"Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels","volume":"40","author":"Matsumoto","year":"2007","journal-title":"Bone Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD009311.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"433a","DOI":"10.1182\/blood.V108.11.1502.1502","article-title":"Infusions of fresh frozen plasma to the patients with a high-risk group for hepatic VOD associated with stem cell transplantation reduce its occurrence","volume":"108","author":"Matsumoto","year":"2006","journal-title":"Blood"},{"issue":"10 Suppl 1 Pt 1","key":"10.1002\/14651858.CD009311.pub2-BIB0015|cit15","first-page":"276a","article-title":"The Japanese multicenter open randomised trial of prophylactic ursodeoxycholic acid for veno-occlusive disease on the liver in patients undergoing stem cell transplantation","volume":"92","author":"Ohashi","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD009311.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomised trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"American Journal of Hematology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009311.pub2-BIB0017|cit17","first-page":"42","article-title":"Prophylaxis of hepatic veno-occlusive disease (VOD) following bone-marrow transplantation (BMT) with low molecular weight heparin (LMHW)","volume":"87","author":"Or","year":"1994","journal-title":"British Journal of Haematology"},{"issue":"7","key":"10.1002\/14651858.CD009311.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","article-title":"Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients","volume":"61","author":"Or","year":"1996","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD009311.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomised trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplantation"},{"issue":"11 Pt 2 of 2 Pa","key":"10.1002\/14651858.CD009311.pub2-BIB0020|cit20","first-page":"854a","article-title":"A randomised trial of heparin plus ursodiol versus heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"98","author":"Park","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD009311.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0022|cit22","first-page":"S198","article-title":"Intravenous versus oral busulfan administration results into a dramatic reduction of veno-occlusive disease (VOD) incidence in a randomised trial assessing fresh frozen plasma+heparin versus heparin-alone as anti-VOD prophylaxis","volume":"47","author":"Yannaki","year":"2012","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD009311.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicenter study demonstrates therapeutic efficacy upon early intervention","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0024|cit24","unstructured":"JPRN-UMIN000013455 Efficacy and safety study of defibrotide (DF) for the prophylaxis of veno-occlusive disease (VOD) apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000013455"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0025|cit25","unstructured":"NCT00563498 A randomized control study on the effects of glutamine on the clinical outcome of bone marrow transplant recipients with special reference to veno-occlusive disease and mucositis www.clinicaltrials.gov\/show\/NCT00563498"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood.V80.12.2964.2964","article-title":"Cytokine dysregulation and acute graft-versus-host disease","volume":"80","author":"Antin","year":"1992","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD009311.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","article-title":"Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients","volume":"32","author":"Barker","year":"2003","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD009311.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.thromres.2005.10.010","article-title":"Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation","volume":"118","author":"Batsis","year":"2006","journal-title":"Thrombosis Research"},{"issue":"11","key":"10.1002\/14651858.CD009311.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"issue":"2-3","key":"10.1002\/14651858.CD009311.pub2-BIB0030|cit30","first-page":"327","article-title":"Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist","volume":"238","author":"Bianchi","year":"1993","journal-title":"Journal of Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009311.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1006\/bbrc.1994.1539","article-title":"Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro","volume":"200","author":"Bracht","year":"1994","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10.1002\/14651858.CD009311.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2141.2009.07871.x","article-title":"Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous busulfan","volume":"147","author":"Capelli","year":"2009","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD009311.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/107602960100700308","article-title":"Tissue factor pathway inhibitor release induced by defibrotide and heparins","volume":"7","author":"Cella","year":"2001","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"10","key":"10.1002\/14651858.CD009311.pub2-BIB0034|cit34","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica"},{"issue":"5","key":"10.1002\/14651858.CD009311.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD009311.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","article-title":"Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation","volume":"40","author":"Cheuk","year":"2007","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD009311.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00609244","article-title":"Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man","volume":"35","author":"Coccheri","year":"1988","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009311.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD009311.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","article-title":"Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide","volume":"38","author":"Corbacioglu","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0040|cit40","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD009311.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome","volume":"22","author":"DeLeve","year":"2002","journal-title":"Seminars in Liver Diseases"},{"issue":"1","key":"10.1002\/14651858.CD009311.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","article-title":"Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease","volume":"40","author":"Dignan","year":"2007","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD009311.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MBC.0b013e32832da1e3","article-title":"The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity","volume":"20","author":"Echart","year":"2009","journal-title":"Blood Coagulation Fibrinolysis"},{"issue":"4","key":"10.1002\/14651858.CD009311.pub2-BIB0044|cit44","first-page":"367","article-title":"Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients","volume":"10","author":"Essell","year":"1992","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD009311.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.leu.2403004","article-title":"Defibrotide reduced procoagulant activity and increases fibrinolytic properties of endothelial cells","volume":"17","author":"Falanga","year":"2003","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009311.pub2-BIB0046|cit46","first-page":"254B","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation (BMT) by continuous infusion of low-dose heparin","volume":"88","author":"Feldman","year":"1996","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD009311.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704087","article-title":"Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study","volume":"31","author":"Forrest","year":"2003","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD009311.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","article-title":"Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation","volume":"74","author":"Gluckman","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0049|cit49","unstructured":"Brozek JL Oxman A Sh\u00fcnneman H GRADEpro. Version 3.2 for Windows 2008"},{"issue":"24","key":"10.1002\/14651858.CD009311.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.1073\/pnas.86.24.10104","article-title":"Increased tumour necrosis factor alpha mRNA after cellular exposure to ionising radiation","volume":"86","author":"Hallahan","year":"1989","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"12","key":"10.1002\/14651858.CD009311.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","article-title":"Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors","volume":"22","author":"Hasegawa","year":"1998","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD009311.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0053|cit53","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0054|cit54","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0055|cit55","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD009311.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.bmt.1703393","article-title":"Veno-occlusive disease of the liver in children with solid tumours undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma","volume":"29","author":"Horn","year":"2002","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD009311.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/cc6943","article-title":"Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxaemic rats","volume":"12","author":"Iba","year":"2008","journal-title":"Critical Care"},{"issue":"7","key":"10.1002\/14651858.CD009311.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD009311.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD009311.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/157488608783333899","article-title":"Busulfan use in hematopoietic stem cell transplantation: pharmacology, dose adjustment, safety and efficacy in adults and children","volume":"3","author":"Krivoy","year":"2008","journal-title":"Current Drug Safety"},{"issue":"8","key":"10.1002\/14651858.CD009311.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bmt.2009.349","article-title":"Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome","volume":"45","author":"Lee","year":"2010","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0062|cit62","unstructured":"Lefebvre C Manheimer E Glanville J (editors) Chapter 6: Searching for studies. In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD009311.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD009311.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"18","author":"McDonald","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009311.pub2-BIB0065|cit65","first-page":"467","article-title":"Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome","volume":"7","author":"Ozkaynak","year":"1991","journal-title":"Bone Marrow Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009311.pub2-BIB0066|cit66","first-page":"15","article-title":"Modulation of venous endothelial activity and transcellular calcium transport by defibrotide: the adenosine hypothesis","volume":"22","author":"Pasini","year":"1996","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"4","key":"10.1002\/14651858.CD009311.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pbc.21425","article-title":"Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children","volume":"50","author":"Qureshi","year":"2008","journal-title":"Pediatric Blood Cancer"},{"issue":"9","key":"10.1002\/14651858.CD009311.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00043426-200212000-00013","article-title":"Hepatic veno-occlusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients","volume":"24","author":"Reiss","year":"2002","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0069|cit69","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD009311.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/pbc.22645","article-title":"Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy","volume":"55","author":"Sakaguchi","year":"2010","journal-title":"Pediatric Blood Cancer"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0071|cit71","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P et al (editors) Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www-cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD009311.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","article-title":"Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin","volume":"27","author":"Simon","year":"2001","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD009311.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3346\/jkms.2006.21.5.897","article-title":"Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children","volume":"21","author":"Song","year":"2006","journal-title":"Journal of Korean Medical Science"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0074|cit74","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009311.pub2-BIB0075|cit75","first-page":"259B","article-title":"Low molecular weight heparin prophylaxis for veno-occlusive disease in unrelated marrow transplant recipients","volume":"88","author":"Styler","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD009311.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD009311.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/1097-0142(19881001)62:7<1275::AID-CNCR2820620705>3.0.CO;2-I","article-title":"Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide","volume":"62","author":"Teicher","year":"1988","journal-title":"Cancer"},{"issue":"9","key":"10.1002\/14651858.CD009311.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbmt.2004.06.004","article-title":"A multi-agent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Thornley","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD009311.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"8","key":"10.1002\/14651858.CD009311.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","article-title":"Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation","volume":"24","author":"Toh","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD009311.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa","year":"1992","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD009311.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1399-0012.2012.01604.x","article-title":"Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review","volume":"26","author":"Zhang","year":"2012","journal-title":"Clinical Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD009311.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0038-1642468","article-title":"Defibrotide stimulates expression of thrombomodulin in human endothelial cells","volume":"71","author":"Zhou","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD009311.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009311","article-title":"Interventions for prophylaxis of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation","author":"Cheuk","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009311.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T06:47:24Z","timestamp":1708757244000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009311.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":84,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009311.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}